Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
72,163,622
-
Share change
-
+10,720,238
-
Total reported value
-
$804,895,770
-
Put/Call ratio
-
44%
-
Price per share
-
$11.15
-
Number of holders
-
200
-
Value change
-
+$125,419,268
-
Number of buys
-
132
-
Number of sells
-
65
Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q3 2020
As of 30 Sep 2020,
SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) was held by
200 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,163,622 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, Cormorant Asset Management, LP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, NORTHERN TRUST CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Nuveen Asset Management, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
200
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.